SUVEN LIFE 2017-18 Annual Report Analysis

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 21st October 2019, due to Assembly Elections in Maharashtra.

SUVEN LIFE 2017-18 Annual Report Analysis
Tue, 14 Aug

SUVEN LIFE has announced its results for the year ended March 2018. Let us have a look at the detailed performance review of the company during FY17-18.

SUVEN LIFE Income Statement Analysis

  • Operating income during the year rose 15.0% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 53.5% YoY during the fiscal. Operating profit margins witnessed a fall and down at 31.7% in FY18 as against 23.7% in FY17.
  • Depreciation charges and finance costs decreased by 0.5% YoY and 18.5% YoY, respectively.
  • Other income grew by 10.3% YoY.
  • Net profit for the year grew by 41.9% YoY.
  • Net profit margins during the year grew from 15.4% in FY17 to 19.1% in FY18.

SUVEN LIFE Income Statement 2017-18

No. of Mths Year Ending 12 Mar-17* 12 Mar-18* % Change
Net Sales Rs m 5,435 6,253 15.0%
Other income Rs m 211 233 10.3%
Total Revenues Rs m 5,646 6,485 14.9%
Gross profit Rs m 1,291 1,982 53.5%
Depreciation Rs m 214 213 -0.5%
Interest Rs m 57 46 -18.5%
Profit before tax Rs m 1,231 1,955 58.9%
Tax Rs m 359 718 100.2%
Profit after tax Rs m 872 1,237 41.9%
Gross profit margin % 23.7 31.7
Effective tax rate % 29.2 36.7
Net profit margin % 15.4 19.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



SUVEN LIFE Balance Sheet Analysis

  • The company's current liabilities during FY18 down at Rs 1 billion as compared to Rs 1 billion in FY17, thereby witnessing an decrease of -1.6%.
  • Long-term debt down at Rs 14 million as compared to Rs 259 million during FY17, a fall of 94.6%.
  • Current assets rose 14% and stood at Rs 6 billion, while fixed assets rose 5% and stood at Rs 3 billion in FY18.
  • Overall, the total assets and liabilities for FY18 stood at Rs 9 billion as against Rs 8 billion during FY17, thereby witnessing a growth of 12%.

SUVEN LIFE Balance Sheet as on March 2018

No. of Mths Year Ending 12 Mar-17* 12 Mar-18* % Change
Networth Rs m 6,670 7,674 15.1
 
Current Liabilities Rs m 1,186 1,168 -1.6
Long-term Debt Rs m 259 14 -94.6
Total Liabilities Rs m 8,157 9,135 12.0
 
Current assets Rs m 4,917 5,622 14.3
Fixed Assets Rs m 3,154 3,325 5.4
Total Assets Rs m 8,157 9,135 12.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



SUVEN LIFE Cash Flow Statement Analysis

  • SUVEN LIFE's cash flow from operating activities (CFO) during FY18 stood at Rs 699 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY18 stood at Rs -6 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY18 stood at Rs -577 million on a YoY basis.
  • Overall, net cash flows for the company during FY18 stood at Rs 116 million from the Rs -2 billion net cash flows seen during FY17.

SUVEN LIFE Cash Flow Statement 2017-18

Particulars No. of months 12 12 % Change
Year Ending Mar-17 Mar-18
Cash Flow from Operating Activities Rs m 1,092 699 -35.9%
Cash Flow from Investing Activities Rs m -3,107 -6 -
Cash Flow from Financing Activities Rs m -304 -577 -
Net Cash Flow Rs m -2,319 116 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



Current Valuations for SUVEN LIFE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 9.7, an improvement from the EPS of Rs 6.9 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 236.4, stands at 17.4 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 3.4 times, while the price to sales ratio stands at 4.1 times.
  • The company's price to cash flow (P/CF) ratio stood at 19.0 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-17* 12 Mar-18*
Sales per share (Unadj.) Rs 42.7 49.1
TTM Earnings per share Rs 6.9 9.7
Diluted earnings per share Rs 7.5 10.6
Price to Cash Flow x 27.7 19.0
TTM P/E ratio x 19.0 17.4
Price / Book Value ratio x 3.6 3.4
Market Cap Rs m 30,089 27,619
Dividends per share (Unadj.) Rs 1.0 1.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



Ratio Analysis for SUVEN LIFE

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 4.8x during FY18, from 4.1x during FY17. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 43.2x during FY18, from 22.7x during FY17. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 16.1% during FY18, from 13.1% during FY18. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 26.0% during FY18, from 18.6% during FY17. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 14.0% during FY18, from 11.4% during FY17. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-17* 12 Mar-18*
Current ratio x 4.1 4.8
Debtors’ Days Days 31 36
Interest coverage x 22.7 43.2
Debt to equity ratio x 0.0 0.0
Return on assets % 11.4 14.0
Return on equity % 13.1 16.1
Return on capital employed % 18.6 26.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



To see how SUVEN LIFE has performed over the last 5 years, please visit here.

SUVEN LIFE Share Price Performance

Over the last one year, SUVEN LIFE share price has moved up from Rs 160.2 to Rs 236.4, registering a gain of Rs 76.2 or around 47.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,664.5 (up 2.3%). Over the last one year it has moved up from 13,090.9 to 14,664.5, a gain of 1,574 points (up 12.0%).

Overall, the S&P BSE SENSEX is up 20.4% over the year.

(To know more, check out historical annual results for SUVEN LIFE and quarterly results for SUVEN LIFE)

Equitymaster requests your view! Post a comment on "SUVEN LIFE 2017-18 Annual Report Analysis". Click here!

  

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS